About BMJ Group media relations team (Emma Dickinson, Caroline White, and Erin Barton)

Our media relations team connects journalists with expert insights and the latest research to support accurate, evidence based healthcare reporting. They manage media interviews, press releases, media inquiries, and publicise key findings from the Group's journals, tools, and services. Contact: mediarelations@bmj.com or +44 (0)7825 118 107

Abdominal fat linked to widespread chronic pain, especially in women

Reducing this fat may reduce chronic pain particularly if it’s at multiple body sites Excess abdominal fat is associated with widespread chronic pain, particularly in women, finds the first study of its kind, published in the open access journal Regional Anesthesia & Pain Medicine. Reducing excess fat deposits in the abdomen ...

Statins cost effective and linked to better health outcomes in older people

Findings back consideration of these drugs for most over-70s, say researchers Statin treatment is cost effective and linked to better health outcomes in older people with or without previous cardiovascular disease, although the risk reductions were substantially smaller in the latter, reports a modelling on the lifetime benefits of these ...

2024-09-11T09:59:44+00:0011 September 2024|Heart, Press release|

Lower diligence level linked to higher cardiovascular disease risk in type 2 diabetes

But adopting healthy lifestyle still beneficial, irrespective of this trait, findings show People with type 2 diabetes, who display lower levels of diligence, may have a significantly higher risk of developing cardiovascular disease with which diabetes is strongly associated, finds research published in the open access journal BMJ Open Diabetes Research ...

Prostate cancer rates across Europe since 1980 “indicative of overdiagnosis” say experts

Findings reinforce need for carefully planned screening programmes to minimise harms of overdiagnosis Rates of prostate cancer across Europe since 1980 are “indicative of overdiagnosis”, say researchers in a study published by The BMJ today. Overdiagnosis refers to the detection of harmless cancers that are unlikely to cause symptoms or death during ...

2024-09-05T09:09:56+00:005 September 2024|Press release, The BMJ|

Number of general practices shrinking but patient lists ballooning in England

Over past decade, practice numbers fell by 20%, but average list size expanded by 40% Total NHS general practice workforce grew 20% in 2015-22, but GP numbers fell by 15% Over the past decade the number of NHS general practices in England has shrunk by 20%, but patient list sizes ...

2024-09-04T10:18:21+00:004 September 2024|BMJ Open, Press release|

Women, Black people, and disadvantaged less likely to get heart surgery in England

And when they are offered these procedures, they are more likely to die within a year Women, people of Black ethnicity, and those from low income households in England are less likely to be offered heart surgery than men, White people, and those who are affluent, finds research published online ...

2024-09-05T10:50:11+00:004 September 2024|Heart, Press release|

Ability to cope well with adversity in older age linked to lower death risk

Findings underscore importance of efforts to bolster mental resilience, say researchers The ability to cope well with, and adapt to, challenging life circumstances and events in older age is linked to a lower risk of death, suggests a large nationally representative study, published in the open access journal BMJ Mental Health. ...

2024-09-04T09:58:22+00:004 September 2024|BMJ Mental Health, Press release|

Certain diabetes drugs might prevent dementia

But randomised controlled trials are needed to confirm these findings Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes might prevent dementia, providing greater benefits with longer treatment, suggests a large study from Korea published by The BMJ today. As this study was observational, the researchers note that the effect size ...

2024-08-29T07:46:52+00:0029 August 2024|Press release, The BMJ|

New study provides further support for psilocybin’s potential to treat depressive symptoms

High dose psilocybin was the only psychedelic treatment to reduce depressive symptoms by more than placebo in antidepressant trials High doses of psilocybin - the active ingredient in magic mushrooms - appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram, suggests ...

2024-08-22T10:48:26+00:0022 August 2024|Press release, The BMJ|
Go to Top